Suzanne Strowig

1.5k total citations
22 papers, 680 citations indexed

About

Suzanne Strowig is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Suzanne Strowig has authored 22 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Suzanne Strowig's work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). Suzanne Strowig is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes Treatment and Management (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). Suzanne Strowig collaborates with scholars based in United States and Norway. Suzanne Strowig's co-authors include Philip Raskin, Larissa Avilés‐Santa, D. Craig Brater, Shirley Anderson, Luis C. Ramirez, Julio Rosenstock, John I. Malone, Jo Ann Ahern, John H. Holcombe and William V. Tamborlane and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

Suzanne Strowig

22 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Strowig United States 15 462 164 136 105 86 22 680
Michael Koffler Israel 12 279 0.6× 124 0.8× 67 0.5× 85 0.8× 99 1.2× 26 627
Supamai Soonthornpun Thailand 13 239 0.5× 98 0.6× 123 0.9× 54 0.5× 84 1.0× 31 512
Charles F. Shaefer United States 10 370 0.8× 129 0.8× 130 1.0× 45 0.4× 132 1.5× 18 702
A Teuscher Switzerland 16 642 1.4× 196 1.2× 111 0.8× 106 1.0× 298 3.5× 32 1.1k
P. M. S. Clark United Kingdom 5 348 0.8× 127 0.8× 161 1.2× 78 0.7× 63 0.7× 8 623
Hüsrev Hatemi Türkiye 15 257 0.6× 55 0.3× 98 0.7× 83 0.8× 65 0.8× 32 534
Tristan Richardson United Kingdom 10 209 0.5× 94 0.6× 63 0.5× 110 1.0× 61 0.7× 28 487
Sylvie Erpeldinger France 7 450 1.0× 87 0.5× 142 1.0× 31 0.3× 109 1.3× 10 676
Matthews Dr United Kingdom 8 767 1.7× 255 1.6× 311 2.3× 59 0.6× 59 0.7× 14 993
Gen Yasuda Japan 15 172 0.4× 123 0.8× 168 1.2× 50 0.5× 317 3.7× 73 790

Countries citing papers authored by Suzanne Strowig

Since Specialization
Citations

This map shows the geographic impact of Suzanne Strowig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Strowig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Strowig more than expected).

Fields of papers citing papers by Suzanne Strowig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Strowig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Strowig. The network helps show where Suzanne Strowig may publish in the future.

Co-authorship network of co-authors of Suzanne Strowig

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Strowig. A scholar is included among the top collaborators of Suzanne Strowig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Strowig. Suzanne Strowig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Budoff, Matthew J., Jye‐Yu C. Backlund, David A. Bluemke, et al.. (2019). The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes. JACC. Cardiovascular imaging. 12(7). 1341–1349. 54 indexed citations
2.
Wang, May-Yun, Xinxin Yu, Young Lee, et al.. (2012). Iatrogenic hyperinsulinemia in type 1 diabetes: Its effect on atherogenic risk markers. Journal of Diabetes and its Complications. 27(1). 70–74. 29 indexed citations
3.
Bohannon, Nancy J.V., Richard M. Bergenstal, Robert Cuddihy, et al.. (2011). Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study. Diabetes Technology & Therapeutics. 13(10). 1031–1037. 16 indexed citations
4.
Strowig, Suzanne & Philip Raskin. (2006). The Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes. Diabetes Care. 29(3). 747–747. 1 indexed citations
5.
Strowig, Suzanne & Philip Raskin. (2005). The Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes. Diabetes Care. 28(7). 1562–1567. 50 indexed citations
6.
Strowig, Suzanne & Philip Raskin. (2004). Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus. Diabetes Obesity and Metabolism. 7(6). 633–641. 26 indexed citations
7.
Strowig, Suzanne, Larissa Avilés‐Santa, & Philip Raskin. (2002). Comparison of Insulin Monotherapy and Combination Therapy With Insulin and Metformin or Insulin and Troglitazone in Type 2 Diabetes. Diabetes Care. 25(10). 1691–1698. 94 indexed citations
8.
Raskin, Philip, John H. Holcombe, William V. Tamborlane, et al.. (2001). A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump. Journal of Diabetes and its Complications. 15(6). 295–300. 60 indexed citations
9.
10.
Strowig, Suzanne & Philip Raskin. (1995). Glycemic control and the complications of diabetes: Afer the diabetes control and complications trial. 3(2). 237–257. 22 indexed citations
11.
Drexler, Andrew, et al.. (1995). Patient-reported experience with velosulin® Human insulin in continuous subcutaneous insulin infusion. Clinical Therapeutics. 17(2). 204–213. 1 indexed citations
12.
Strowig, Suzanne. (1993). Initiation and Management of Insulin Pump Therapy. The Diabetes Educator. 19(1). 50–58. 8 indexed citations
13.
Giles, Donna E., et al.. (1992). Personality traits as predictors of good diabetic control. Journal of Diabetes and its Complications. 6(2). 101–104. 6 indexed citations
14.
Strowig, Suzanne & Philip Raskin. (1992). Glycemic Control and Diabetic Complications. Diabetes Care. 15(9). 1126–1140. 49 indexed citations
15.
Ramirez, Luis C., Anthony Dal Nogare, Connie C. W. Hsia, et al.. (1991). Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. The American Journal of Medicine. 91(4). 371–376. 55 indexed citations
16.
Ramirez, Luis C., et al.. (1990). Effective treatment of bulimia with fluoxetine, a serotonin reuptake inhibitor, in a patient with type I diabetes mellitus. The American Journal of Medicine. 88(5). 540–541. 18 indexed citations
17.
Rosenstock, Julio, et al.. (1988). Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice. 4(3). 167–175. 13 indexed citations
18.
Strowig, Suzanne. (1982). Patient Education: A Model for Autonomous Decision-Making and Deliberate Action in Diabetes Self-Management. Medical Clinics of North America. 66(6). 1293–1307. 21 indexed citations
19.
Brater, D. Craig, Shirley Anderson, & Suzanne Strowig. (1979). A comparison of azosemide, a new loop diuretic, to furosemide. Clinical Pharmacology & Therapeutics. 25(2). 215–216. 11 indexed citations
20.
Brater, D. Craig, Shirley Anderson, & Suzanne Strowig. (1979). Azosemide, a “loop” diuretic, and furosemide. Clinical Pharmacology & Therapeutics. 25(4). 435–439. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Koffler Breakdown of academic impact, for papers by Supamai Soonthornpun Breakdown of academic impact, for papers by Charles F. Shaefer Breakdown of academic impact, for papers by A Teuscher Breakdown of academic impact, for papers by P. M. S. Clark Breakdown of academic impact, for papers by Hüsrev Hatemi Breakdown of academic impact, for papers by Tristan Richardson Breakdown of academic impact, for papers by Sylvie Erpeldinger Breakdown of academic impact, for papers by Matthews Dr Breakdown of academic impact, for papers by Gen Yasuda
Rankless by CCL
2026